DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider.

Slides:



Advertisements
Similar presentations
Keynote Address: Issues to Tackle David Nabarro Vienna Senior Officials Meeting on Avian and Pandemic Influenza 7 th June 2006.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Global Risk Identification Program WMO 15 th Congress Side event on strengthening national and regional partnerships on disaster risk reduction.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
AGENDA ITEM 4: FOLLOW-UP ON THE DECISIONS OF THE WORLD METEOROLOGICAL CONGRESS ON THE INTERGOVERNMENTAL BOARD ON CLIMATE SERVICES AGENDA ITEM 4.1: IMPLEMENTATION.
Health and Sustainable Development: HIV in the Post Development Agenda Steve Kraus Director, Regional Support Team for Asia and the Pacific UNAIDS.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
A Global Framework for Public Health Functions Taskforce for World Federation of Public Health Associations Draft for discussion 15 th May 2014.
Pandemic Influenza Catherine Donovan, MD. MHSc. CIPHI, Newfoundland and Labrador, Oct 25, 2005 Eastern Region
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
International Regulatory Capacity Building Global Curriculum Project.
The Quality Management System
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Central Asia Regional Health Security Workshop Co-organized with the Command Surgeon, US Central Command and the George C. Marshall European Center for.
Health promotion and health education programs. Assumptions of Health Promotion Relationship between Health education& Promotion Definition of Program.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,
Initial thoughts on a Global Strategy for the Implementation of the SEEA Central Framework Ivo Havinga United Nations Statistics Division.
Controlling and Eradicating Highly Pathogenic Avian Influenza in ASEAN Dr. Wilfrido V. Villacorta ASEAN Deputy Secretary-General International Pledging.
TASK FORCE ON WRDs SURVEILLANCE TASK FORCE ON WRDs SURVEILLANCE Monica Francesca Blasi, Paola Meli, Mario Carere, Enzo Funari National Institute of Health.
PROSPECTS FOR FUTURE COOPERATION WITHIN LATVIA-RUSSIA ENI CBC PROGRAMME ILZE KRIEVA EST-LAT-RUS Annual event, Gatchina, 2014.
Progress on Planning for Deployment Geneva, 16 April 2015 Advisory Group Meeting.
SEARO –CSR Early Warning and Surveillance System Module International Health Regulations and EWAR.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Workshop on RISKS AND IMPACTS ON FLOOD FROM EXTREME EVENTS IN ASEAN COUNTRIES Bali, August 5 th 2015.
PORTFOLIO COMMITTEE PRESENTATION Ms. Joyce Mogale (Interim CEO) Prof. Perez (Chair ) Supporting a long and healthy life for all South Africans NHLS ANNUAL.
Daniel Kull Senior Disaster Risk Management Specialist Global Facility for Disaster Reduction and Recovery (GFDRR) World Bank Geneva, 19 November, 2012.
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
Council on Health Research for Development Foro de investigación en Salud de Argentina Fijación de prioridades de investigación sanitaria: de la agenda.
Pandemic Preparedness Rome | June |1 | Pandemic Preparedness FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian Influenza, June,
9th EIONET Workshop on Climate Change Impacts, Vulnerability and Adaptation James Creswick, Technical Officer Climate change, green health services and.
UN-Water Global Annual Assessment of Sanitation and Drinking-Water 1 |1 | Water Country Briefs diagnostic workshop 9-10 December 2010 Geneva UN-Water GLAAS.
A Framework for Developing a Public Agenda for Illinois Higher Education: Planning for College and Career Success Presented to the Illinois Board of Higher.
Establishing a Global Vaccine Development Fund Peter Hale The Foundation for Vaccine Research Washington, DC Consultation on Financing of R&D Preparedness.
Interactions between health systems and Global Health Initiatives – what we learnt to inform research methodology Joseph Perriëns on behalf of Badara Samb.
Country Partnership Strategy FY12-16 Consultations with Civil Society The World Bank Group June 2, 2011.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Non-institutionalized adults vaccinated annually against influenza and ever vaccinated against pneumococcal disease. Healthy Kansans 2010 Steering Committee.
Advisory Forum, July 2005 Outcome of the first retreat of ECDC Management Team (EXC) 4-5 July 2005 Krägga Herrgård Zsuzsanna Jakab Director ECDC.
BP10 Public Health Emergency Preparedness Grant Update Health & Medical Subpanel Pandemic Influenza Advisory Committee Meeting January 12, 2010 Mark J.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
GLOBAL HEALTH By Maressa Rodgers. Goal Improve public health and strengthen U.S. national security through global disease detection, response, prevention,
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
One Health meeting Day one summary report Rapporteurs Cameroon and Uganda 12 Nov 2012.
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
WHO project to generate
Technical Consultation: Folate Status in Women and NTD Risk-Reduction
Overview of the Objectives, Expected Outcomes, and Meeting Agenda
WHO Country Office, Ghana
PIHOA Regional Lab Coordinator PIHOA 60th Meeting - Honolulu, HI
Is E2 sufficient to ensure sustainability?
National health policy review
Pandemic Influenza Preparedness Planning
World Health Organization
WHO Global Influenza Programme
The Role of NICs in Influenza Surveillance
Good Governance of Animal Health Systems
PEFA Assessments - Analytics to Action
NDPHS Work Plan for 2012 NDPHS 8th Partnership Annual Conference
Dr Timothy Armstrong Coordinator
Core Capacity Monitoring Evaluation Unit
Presentation transcript:

DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries

2 | Background  PIP Framework requires an annual contribution to WHO from influenza vaccine, diagnostic & pharmaceutical manufacturers that use WHO Global Influenza Surveillance and Response System (GISRS)  PIP Framework specifies that Partnership Contribution (PC) is to be used for two purposes:  Inter-pandemic preparedness (70%)  Response activities in the event of a pandemic (30%)

3 | Advisory Group (AG) request “The method by which factors will be applied in the selection of countries to receive PC funds will be developed by WHO and shared with the AG at its next meeting in October."* *Advisory Group Recommendations to the Director-General on Potential Uses of PIP Partnership Contribution Resources for Pandemic Preparedness and Response, 16 May 2012

4 | The PC allocations should Take into account Framework principles including fairness, equity, public health risk and need of all Member States and the particular vulnerability of H5N1 Be evidence based and consider indicators adapted to the Framework such as IHR core capacity, income, health and epidemiology Consider the critical foundation of epidemiological and laboratory surveillance Take into account the modest amount of PC resources

5 | Develop a method that:  Is simple so that the process can be easily understood  Is based on reliable and widely accepted information  Promotes the Principles of the PIP Framework Goals

6 | Overview of the method for Risk and Needs Assessment (RNA) 1.As per PIP Framework recommendation, focus should be on: (i) developing Member States, (ii) IHR core capacity, (iii) needs for influenza surveillance; and (iv) H5N1 vulnerability 2.Select factors to establish profiles of needs 3.Give weight to each factor

7 | From RNA to Implementation process Risk and Needs Assessment based on identified priorities Pool of countries in needs Selection of the first cohort of countries based on Profile of needs Sustainability Regional dynamics Etc. Work plan for 2 years

8 | Three factors to consider to assess Member States  Developing Country Status  Degree of development of laboratory/epidemiological surveillance system  Whether the country is affected by H5N1

9 | Other uses of the Partnership contribution For burden of diseases studies, risk communication and regulatory capacities, the approach will be adapted to the limited amount of PC resources. A work plan will be developed for 3 years to ensure the best use possible of these limited resources –Taking into account investments already made by other donors on burden of disease studies –Finding synergy with other WHO activities on risk communication and regulatory capacity building

10 | Thank you 谢谢 Merci Obrigada شكرا Gracias